Studies will be undertaken with model antibodies to disect the contribution of different portions of the antibody variable regions to antigen binding. One series of experiments will determine the structural requirements for high affinity binding by a stepwise conversion of the amino acid sequence of a lower affinity mouse antibody directed against azophenylarsonate (Ars) into the sequence of a higher affinity one. Another series of experiments will involve interchanging portions of the variable regions of a mouse anti-Ars antibody with those of a mouse anti-Alpha(1-6) dextran antibody. This will include testing the hypothesis that the hypervariable regions alone carry the antibody specificity and will retain it when inserted into another framework. The above experiments will be accomplished using site directed in vitro mutagenesis of cloned antibody genes, and introduction of these genes into appropriate myeloma or hybridoma cell lines. The mutant antibodies produced will be tested for antigen binding specificity and affinity and for idiotypic expression using standard immunological methods. These studies will increase our understanding of the structural requirements for antibody specificity and affinity, and of the structure - function relationship and folding of proteins in general. They will help develop the knowledge to design tailor - made antibodies for research and medical purposes.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI023909-02
Application #
3136462
Study Section
Allergy and Immunology Study Section (ALY)
Project Start
1986-07-01
Project End
1990-06-30
Budget Start
1987-07-01
Budget End
1988-06-30
Support Year
2
Fiscal Year
1987
Total Cost
Indirect Cost
Name
Boston University
Department
Type
Schools of Medicine
DUNS #
604483045
City
Boston
State
MA
Country
United States
Zip Code
02118
Liebman, Meredith A; Roche, Marly I; Williams, Brent R et al. (2007) Antibody treatment of human tumor xenografts elicits active anti-tumor immunity in nude mice. Immunol Lett 114:16-22
Sharon, Jacqueline; Liebman, Meredith A; Williams, Brent R (2005) Recombinant polyclonal antibodies for cancer therapy. J Cell Biochem 96:305-13
Liebman, Meredith A; Williams, Brent R; Daley, Kylle M et al. (2004) Generation and preliminary characterization of an antibody library with preferential reactivity to human colorectal cancer cells as compared to normal human blood cells. Immunol Lett 91:179-88
Chen, Liyan; Liebman, Meredith A; Teodorescu-Frumosu, Sanda et al. (2003) Expression of a prototypic anti-colorectal cancer polyclonal antibody library in mammalian cells. Immunol Lett 88:135-40
Sharon, Jacqueline; Sompuram, Seshi R; Yang, Chiou-Ying et al. (2002) Construction of polyclonal antibody libraries using phage display. Methods Mol Biol 178:101-12
Williams, Brent R; Sharon, Jacqueline (2002) Polyclonal anti-colorectal cancer Fab phage display library selected in one round using density gradient centrifugation to separate antigen-bound and free phage. Immunol Lett 81:141-8
Williams, Brent R; Sompuram, Seshi R; Sharon, Jacqueline (2002) Generation of anti-colorectal cancer fab phage display libraries with a high percentage of diverse antigen-reactive clones. Comb Chem High Throughput Screen 5:489-99
Sharon, J; Sarantopoulos, S; Den, W et al. (2000) Recombinant polyclonal antibody libraries. Comb Chem High Throughput Screen 3:185-96
Santora, K E; Sarantopoulos, S; Den, W et al. (2000) Generation of a polyclonal fab phage display library to the human breast carcinoma cell line BT-20. Comb Chem High Throughput Screen 3:51-7
Sompuram, S R; Den, W; Sharon, J (1996) Analysis of antigen binding and idiotypic expression by antibodies with polyglycine-replaced complementarity-determining regions. J Immunol 156:1071-81

Showing the most recent 10 out of 25 publications